We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.91B
AUM Growth
-$33.5M
Cap. Flow
-$96.8M
Cap. Flow %
-1.4%
Top 10 Hldgs %
55.6%
Holding
295
New
67
Increased
47
Reduced
98
Closed
74

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$81.6M
2
NVRO
NEVRO CORP.
NVRO
+$68M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$61.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$55.5M
5
KDP icon
Keurig Dr Pepper
KDP
+$44.2M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$105M
2
OGN icon
Organon & Co
OGN
+$75.3M
3
EXAS
Exact Sciences
EXAS
+$69M
4
BIIB icon
Biogen
BIIB
+$57.7M
5
CENTA icon
Central Garden & Pet Co Class A
CENTA
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 39.29%
2 Consumer Staples 5.94%
3 Technology 4.58%
4 Consumer Discretionary 4.41%
5 Communication Services 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYRA
76
DELISTED
LYRA THERAPEUTICS INC
LYRA
$16.5M 0.24%
+80,241
New +$11.1M
ROST icon
77
Ross Stores
ROST
$81.1B
$15.7M 0.23%
140,000
-60,000
-30% -$6.31M
STZ icon
78
Constellation Brands
STZ
$22.4B
$14.8M 0.21%
60,000
+57,508
+2,308% +$13.5M
SMPL icon
79
Simply Good Foods
SMPL
$1B
$14.6M 0.21%
400,000
+60,018
+18% +$2.21M
GERN icon
80
Geron
GERN
$821M
$14.4M 0.21%
+4,500,000
New +$12.8M
FL
81
DELISTED
Foot Locker
FL
$13.3M 0.19%
490,000
-10,000
-2% -$340K
LULU icon
82
lululemon athletica
LULU
$14B
$13.2M 0.19%
35,000
-15,000
-30% -$5.53M
ESPR
83
DELISTED
Esperion Therapeutics
ESPR
$12.8M 0.18%
9,193,000
+5,513,721
+150% +$7.7M
KYNB
84
Kyntra Bio
KYNB
$27.4M
$11.8M 0.17%
174,240
+81,760
+88% +$33.8M
TGNA
85
DELISTED
TEGNA Inc
TGNA
$11.8M 0.17%
724,000
-32,000
-4% -$521K
ADBE icon
86
Adobe
ADBE
$99.9B
$11.7M 0.17%
24,000
-16,000
-40% -$6.45M
PATH icon
87
UiPath
PATH
$6.76B
$11M 0.16%
+664,000
New +$10.6M
NARI
88
DELISTED
Inari Medical, Inc. Common Stock
NARI
$10.9M 0.16%
188,000
+52,000
+38% +$3.28M
ORLY icon
89
O'Reilly Automotive
ORLY
$73.3B
$10.8M 0.16%
169,500
-51,000
-23% -$3.11M
TSN icon
90
Tyson Foods
TSN
$21B
$10.7M 0.16%
210,000
-88,000
-30% -$4.79M
GSK icon
91
GSK
GSK
$103B
$10.7M 0.15%
300,000
-2,936,000
-91% -$105M
CROX icon
92
Crocs
CROX
$6.47B
$10.7M 0.15%
+95,000
New +$11.3M
WYNN icon
93
Wynn Resorts
WYNN
$10.2B
$10.6M 0.15%
100,000
-4,865
-5% -$521K
CMG icon
94
Chipotle Mexican Grill
CMG
$47.5B
$10.4M 0.15%
242,500
-217,500
-47% -$8.6M
DYN icon
95
Dyne Therapeutics
DYN
$4.71B
$10.3M 0.15%
+912,000
New +$10.8M
FIVN icon
96
FIVE9
FIVN
$2.22B
$10.2M 0.15%
124,000
-24,000
-16% -$1.61M
ATVI
97
DELISTED
Activision Blizzard
ATVI
$9.1M 0.13%
108,000
-60,000
-36% -$4.86M
HZNP
98
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$9.05M 0.13%
88,000
-120,000
-58% -$12.7M
INMD icon
99
InMode
INMD
$882M
$8.81M 0.13%
+236,000
New +$8.25M
FREE
100
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$8.64M 0.13%
2,150,000
– –
2 3
4
5 6

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Armistice Capital held 295 positions worth $6.91B, down 0.48% from $6.94B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital's Q2 2023 filing shows 67 new, 47 increased, 98 reduced and 74 closed positions. Its largest new stake was Pfizer: 2,096,000 shares worth $76.9M. The largest sale was GSK, an estimated $105M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q2 2023 buy was Pfizer: 2,096,000 shares worth $76.9M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2023, an estimated $55.5M increase.
  • Armistice Capital's biggest Q2 2023 reduction was GSK, cutting an estimated $105M.
  • Armistice Capital fully exited Organon & Co in Q2 2023, selling an estimated $75.3M.
  • Armistice Capital's ten largest holdings make up 56% of its $6.91B portfolio in Q2 2023.
  • Armistice Capital opened 67 new positions and closed 74 in Q2 2023.
  • Armistice Capital's portfolio value fell 0.48% quarter-over-quarter to $6.91B.

Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.